Rekvina Laboratories Limited (BOM:526075)
21.88
+0.42 (1.96%)
At close: Feb 12, 2026
Rekvina Laboratories Revenue
Rekvina Laboratories had revenue of 3.46M INR in the quarter ending December 31, 2025. This brings the company's revenue in the last twelve months to 5.42M.
Revenue (ttm)
5.42M
Revenue Growth
n/a
P/S Ratio
24.81
Revenue / Employee
1.08M
Employees
5
Market Cap
134.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunrest Lifescience | 520.34M |
| Cian Healthcare | 232.80M |
| Beryl Drugs | 176.65M |
| Unjha Formulations | 148.12M |
| Norris Medicines | 72.84M |
| Hamps Bio | 71.20M |
| Desh Rakshak Aushdhalaya | 62.53M |
| Colinz Laboratories | 58.40M |